GH35 / Genhouse Bio  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GH35 / Genhouse Bio
NCT05010694: Dose Finding Study of GH35 in Patients With Advanced Solid Tumors

Active, not recruiting
1
18
RoW
GH35 Tablet
Suzhou Genhouse Bio Co., Ltd.
AdvAdvanced Solid Tumors, Kirsten Rat Sarcoma
03/23
12/25

Download Options